PubRank

Eric A Johnson

Author PubWeight™ 157.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rapid SNP discovery and genetic mapping using sequenced RAD markers. PLoS One 2008 13.64
2 Population genomics of parallel adaptation in threespine stickleback using sequenced RAD tags. PLoS Genet 2010 7.05
3 The Group Health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood) 2010 6.60
4 Rapid and cost-effective polymorphism identification and genotyping using restriction site associated DNA (RAD) markers. Genome Res 2006 5.80
5 SV2 is the protein receptor for botulinum neurotoxin A. Science 2006 4.51
6 Construction and application for QTL analysis of a Restriction Site Associated DNA (RAD) linkage map in barley. BMC Genomics 2011 3.42
7 Single-cell microbiology: tools, technologies, and applications. Microbiol Mol Biol Rev 2004 2.53
8 RAD marker microarrays enable rapid mapping of zebrafish mutations. Genome Biol 2007 2.07
9 Local de novo assembly of RAD paired-end contigs using short sequencing reads. PLoS One 2011 1.98
10 Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 2006 1.97
11 SNP discovery and genotyping for evolutionary genetics using RAD sequencing. Methods Mol Biol 2011 1.96
12 An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proc Natl Acad Sci U S A 2007 1.85
13 Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications. Curr Microbiol 2003 1.83
14 Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 2003 1.81
15 High-density detection of restriction-site-associated DNA markers for rapid mapping of mutated loci in Neurospora. Genetics 2007 1.78
16 Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell 2008 1.66
17 Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl Environ Microbiol 2008 1.62
18 A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J Mol Biol 2006 1.59
19 Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology 2008 1.52
20 Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem Biophys Res Commun 2007 1.52
21 Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob Agents Chemother 2003 1.47
22 The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability. Protein Expr Purif 2004 1.45
23 Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters. Appl Environ Microbiol 2008 1.44
24 Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc Natl Acad Sci U S A 2004 1.40
25 A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett 2007 1.40
26 Subunit vaccine against the seven serotypes of botulism. Infect Immun 2007 1.39
27 Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916. Anaerobe 2004 1.30
28 Bleeding stomal varices: case series and systematic review of the literature. Clin Gastroenterol Hepatol 2008 1.29
29 Safety of using a computerized rounding and sign-out system to reduce resident duty hours. Acad Med 2010 1.29
30 Identification of a lycopene beta-cyclase required for bacteriorhodopsin biogenesis in the archaeon Halobacterium salinarum. J Bacteriol 2002 1.28
31 Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proc Natl Acad Sci U S A 2009 1.26
32 Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum. FEMS Microbiol Lett 2004 1.25
33 Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog 2011 1.24
34 Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination. J Pharmacol Toxicol Methods 2010 1.21
35 Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci 2012 1.21
36 Effects of purification on the bioavailability of botulinum neurotoxin type A. Toxicology 2008 1.16
37 Secular trends in colon and rectal cancer relative survival. J Natl Cancer Inst 2013 1.16
38 SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog 2010 1.15
39 Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol 2007 1.15
40 Spreading a medical home redesign: effects on emergency department use and hospital admissions. Ann Fam Med 2013 1.15
41 A survey of new temperature-sensitive, embryonic-lethal mutations in C. elegans: 24 alleles of thirteen genes. PLoS One 2011 1.15
42 Amyloidosis presenting as lower gastrointestinal hemorrhage. WMJ 2008 1.11
43 Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro. Infect Immun 2013 1.10
44 Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E. Infect Immun 2005 1.10
45 Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex. Appl Environ Microbiol 2009 1.09
46 Recombinant holotoxoid vaccine against botulism. Infect Immun 2007 1.09
47 Elevated CO2 suppresses specific Drosophila innate immune responses and resistance to bacterial infection. Proc Natl Acad Sci U S A 2009 1.09
48 Genomic patterns of introgression in rainbow and westslope cutthroat trout illuminated by overlapping paired-end RAD sequencing. Mol Ecol 2013 1.09
49 Conjugative botulinum neurotoxin-encoding plasmids in Clostridium botulinum. PLoS One 2010 1.08
50 Identification and function of hypoxia-response genes in Drosophila melanogaster. Physiol Genomics 2006 1.07
51 Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett 2010 1.07
52 Receptor binding enables botulinum neurotoxin B to sense low pH for translocation channel assembly. Cell Host Microbe 2011 1.06
53 Microfluidic tectonics platform: A colorimetric, disposable botulinum toxin enzyme-linked immunosorbent assay system. Electrophoresis 2004 1.04
54 Obtaining informed consent for genetic studies: The multiethnic study of atherosclerosis. Am J Epidemiol 2006 1.04
55 Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1. J Biol Chem 2006 1.02
56 Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222. Appl Environ Microbiol 2011 1.02
57 Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival. Nat Commun 2013 0.99
58 Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry 2009 0.99
59 Expression profiling of zebrafish sox9 mutants reveals that Sox9 is required for retinal differentiation. Dev Biol 2009 0.97
60 Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins. J Cell Sci 2012 0.96
61 Facile and rapid DNA extraction and purification from food matrices using IFAST (immiscible filtration assisted by surface tension). Analyst 2012 0.95
62 Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain). PLoS One 2009 0.93
63 Impact on seniors of the patient-centered medical home: evidence from a pilot study. Gerontologist 2012 0.93
64 Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists. FEBS Lett 2002 0.93
65 Lipid diversity among botulinum neurotoxin-producing clostridia. Microbiology 2012 0.92
66 Characterization of the epitope region of F1-2 and F1-5, two monoclonal antibodies to Botulinum neurotoxin type A. Hybridoma (Larchmt) 2009 0.91
67 Outcomes among chronically ill adults in a medical home prototype. Am J Manag Care 2013 0.91
68 Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies. Appl Environ Microbiol 2009 0.91
69 Sgt1 acts via an LKB1/AMPK pathway to establish cortical polarity in larval neuroblasts. Dev Biol 2012 0.90
70 Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells. Biochem Biophys Res Commun 2010 0.90
71 Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase. Bioorg Med Chem Lett 2009 0.90
72 Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C. Eur J Neurosci 2007 0.89
73 Recent advances in crustacean genomics. Integr Comp Biol 2008 0.88
74 Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies. Bioorg Med Chem 2012 0.88
75 Massively parallel characterization of restriction endonucleases. Nucleic Acids Res 2013 0.87
76 Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells. Infect Immun 2011 0.87
77 Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A. Biochem Biophys Res Commun 2011 0.87
78 Stimulation of astaxanthin formation in the yeast Xanthophyllomyces dendrorhous by the fungus Epicoccum nigrum. FEMS Yeast Res 2004 0.86
79 Validity of botulinum neurotoxin serotype H. J Infect Dis 2014 0.86
80 Targeting botulinum A cellular toxicity: a prodrug approach. J Med Chem 2013 0.86
81 Association of toxin-producing Clostridium botulinum with the macroalga Cladophora in the Great Lakes. Environ Sci Technol 2013 0.86
82 Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH. Biochemistry 2012 0.85
83 Purification and characterization of a novel subtype a3 botulinum neurotoxin. Appl Environ Microbiol 2012 0.85
84 Predictors of malignancy and recommended follow-up in patients with negative endoscopic ultrasound-guided fine-needle aspiration of suspected pancreatic lesions. Can J Gastroenterol 2009 0.85
85 Design and evaluation of 16S rRNA-targeted peptide nucleic acid probes for whole-cell detection of members of the genus Listeria. Appl Environ Microbiol 2005 0.85
86 Clostridium botulinum strains producing BoNT/F4 or BoNT/F5. Appl Environ Microbiol 2014 0.84
87 Toward the discovery of dual inhibitors for botulinum neurotoxin A: concomitant targeting of endocytosis and light chain protease activity. Chem Commun (Camb) 2015 0.83
88 Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells. Infect Immun 2013 0.83
89 Function-oriented synthesis applied to the anti-botulinum natural product toosendanin. Bioorg Med Chem 2008 0.83
90 Symptomatic hibernoma: a rare soft tissue tumor. Hawaii J Med Public Health 2012 0.82
91 Partial protection against Botulinum B neurotoxin-induced blocking of exocytosis by a potent inhibitor of its metallopeptidase activity. Chembiochem 2005 0.82
92 Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease. Biopolymers 2003 0.82
93 Rapid mapping and identification of mutations in Caenorhabditis elegans by restriction site-associated DNA mapping and genomic interval pull-down sequencing. Genetics 2011 0.82
94 Bead-based microfluidic toxin sensor integrating evaporative signal amplification. Lab Chip 2008 0.82
95 Self-assembled peptide monolayers as a toxin sensing mechanism within arrayed microchannels. Anal Chem 2009 0.82
96 Subunit vaccine efficacy against Botulinum neurotoxin subtypes. Vaccine 2011 0.81
97 Enhancing the protective immune response against botulism. Infect Immun 2013 0.81
98 A microscale neuron and Schwann cell coculture model for increasing detection sensitivity of botulinum neurotoxin type A. Toxicol Sci 2013 0.81
99 Endoscopic ultrasound-guided pancreatic pseudocyst cystogastrostomy using a novel self-expandable metal stent with antimigration system: A case series. Endosc Ultrasound 2015 0.81
100 Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5. Biochim Biophys Acta 2013 0.80
101 Delineating the susceptibility of botulinum neurotoxins to denaturation through thermal effects. FEBS Lett 2008 0.80
102 The association of depression and preferences for life-sustaining treatments in veterans with chronic obstructive pulmonary disease. J Pain Symptom Manage 2010 0.80
103 Antibotulinal activity of process cheese ingredients. J Food Prot 2004 0.79
104 Using hyper as a molecular probe to visualize hydrogen peroxide in living plant cells: a method with virtually unlimited potential in plant biology. Methods Enzymol 2013 0.79
105 Synaptotagmin II peptide-bead conjugate for botulinum toxin enrichment and detection in microchannels. Biosens Bioelectron 2010 0.78
106 Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype B. Bioorg Med Chem Lett 2008 0.78
107 Inhibition of the ATPase activity of the catalytic portion of ATP synthases by cationic amphiphiles. Biochim Biophys Acta 2008 0.78
108 Synthesis of soluble multivalent glycoconjugates that target the Hc region of botulinum neurotoxin A. Bioorg Med Chem Lett 2007 0.78
109 Model for studying Clostridium botulinum neurotoxin using differentiated motor neuron-like NG108-15 cells. Biochem Biophys Res Commun 2012 0.77
110 Retargeted clostridial neurotoxins as novel agents for treating chronic diseases. Biochemistry 2011 0.77
111 Measurement in comparative effectiveness research. Am J Prev Med 2013 0.77
112 Genome Sequence of the Group III Clostridium botulinum Strain Eklund-C. Genome Announc 2013 0.76
113 Genetic manipulation of Xanthophyllomyces dendrorhous and Phaffia rhodozyma. Methods Mol Biol 2012 0.76
114 Clostridium taeniosporum is a close relative of the Clostridium botulinum Group II. Anaerobe 2008 0.76
115 C-Terminal mutations in the chloroplast ATP synthase gamma subunit impair ATP synthesis and stimulate ATP hydrolysis. Biochemistry 2007 0.76
116 Genomic resources notes accepted 1 December 2014 - 31 January 2015. Mol Ecol Resour 2015 0.75
117 Isolation of carotenoid hyperproducing mutants of Xanthophyllomyces dendrorhous (Phaffia rhodozyma) by flow cytometry and cell sorting. Methods Mol Biol 2012 0.75
118 Toosendanin: synthesis of the AB-ring and investigations of its anti-botulinum properties (Part II). Bioorg Med Chem 2009 0.75
119 Multiple domains of tetanus toxin direct entry into primary neurons. Traffic 2014 0.75
120 Visual evaluation of the larynx and hypopharynx during esophagogastroduodenoscopy: a safety and feasibility study. Surg Endosc 2014 0.75
121 Immunodetection of small o-phenylenebismaleimide-labeled peptides through carrier protein display on polyvinylidene fluoride. Anal Biochem 2002 0.75
122 Factors that contribute to the botulinal safety of reduced-fat and fat-free process chesse products. J Food Prot 2004 0.75